Table 1.
Scaffolds loaded with EVs and their potential healing effects
| EV characteristics |
|||||
|---|---|---|---|---|---|
| Scaffold material | EVs source | Size | Surface markers | Therapeutic effects | Reference |
| Chitosan glycerol hydrogel | Human endometrial stem cell (hEnSC) | 40–150 nm | CD63 | Angiogenesis, epithelial layer, and formation of granular tissue development were improved. | Nooshabadi et al.78 |
| Hyaluronic acid | HUC mononuclear cells | 100–130 nm | CD9, 63, 81, tumor necrosis factor 101 | Increased vascular density, faster wound healing, and full epithelialization. | Mao et al.24 |
| Methylcellulose chitosan hydrogel | Placental MSCs | about 62.5 nm | CD9, 63, 81 | Increased migration of fibroblasts, angiogenesis, re-epithelialization. Inhibition of apoptosis. | Wang et al.79 |
| Chitosan and silk | Human gingival MSCs | 127 nm | CD9, 81 | Wound healing was faster, neoepithelialization was more abundant, collagen was deposited, collagen was wavy. | Shi et al.80 |
| Pluronic F-127, oxidative hyaluronic acid, poly-€-L-lysine based skin graft | ASCs | 60–80 nm | CD9,63,8, Alix | Closure of the wound, formation of new dermal appendages, collagen deposition, and re-epithelialization. | Tao et al.81 |
| Human acellular amniotic membrane (hAAM) | AdMSCs | 47.7–150 nm | CD9, CD81 | Faster ulcer healing, augmented vascularization, increased ECM production, and deposition of collagen. | Xiao et al.82 |
| PEI grafted Pluronic F-127 and aldehyde pullulan | Mouse ASCs | not reported | not reported | EV gel group took less time to repair wounds and deposited more collagen. | Wang et al.83 |
| Chitosan and silk | Human PRP | not reported | not reported | In the EV-gel group, wounds closed faster, fewer skin ulcers developed, collagen deposition was greater, and vessel density was higher. | Xu et al.84 |
| Matrigel | HUC- Wharton’s jelly | 30–100 nm | CD81 | In comparison with gel alone, EV gel promoted wound closure and collagen deposition. | Bakhtyar et al.85 |
| Peptide | Human uMSCs | 100–1,000 nm | CD63,81 | In comparison with a blank formulation, uMSCs demonstrated full wound closure, less scar formation, greater expression of the growth factor-SMA, and well-arrangement of healed tissue. | Fang et al.86 |
| Alginate-based hydrogel | ADSCs | not reported | Akt, ERK, STAT3 | Vasculature, scar tissue, re-epithelialization, and granulation tissue formation on the wound surface. | Shafei et al.44 |
| Pluronic F-127 | hUCMSC-Exo | not reported | CD31, Ki67 | Improved exosome ability, improvement in granulation tissue regeneration, and irregular vascular endothelial growth factor expression, potential to improve diabetic wound healing. | Yang et al.87 |
| SIS/MBG based hydrogel | BMSC | not reported | CD9, CD63 | Promote granulation tissue formation, well-organized collagen fiber deposition, functional new blood vessel growth. | Hu et al.88 |
| PVA/alginate nanohydrogel | HUCMSCs | not reported | SMA, SR-B1, CD31, CD29, CD34 | Facilitate the proliferation, migration, and angiogenesis of HUVECs and speed up the process of diabetic wound healing. | Zhang et al.89 |
| Polyurethane based oxygen releasing scaffolds | ADSCs | 200 nm | CD81 | Facilitated faster wound closure, enhanced collagen deposition, faster re-epithelialization, and decreased oxidative stress within two weeks. | Shiekh et al.90 |
| Gelatin methacryloyl hydrogel | HUVECs | 50–140 nm | CD9, CD63, CD81 | The in vivo results showed accelerated re-epithelialization, promotion of collagen maturity and improvement of angiogenesis. | Zhao et al.91 |